Description:

Naples Brunch 2026 | Naples, Florida
Friday March 6, 2026 | 11 a.m. EST

The Northwestern Club of Southwest Florida and the Half Century Club of Northwestern University’s Medical Alumni Association invite you to our annual Feinberg Naples Brunch.

Game-Changing GLP-1 Obesity Medications: Exciting Breakthroughs But Challenges Remain

Welcome Reception: 11–11:30 a.m.
Program and Brunch: 11:30 a.m. (Begins promptly)

This year’s program offers a rare opportunity to hear from one of the world’s foremost authorities on metabolic health: Robert F. Kushner, MD, ’82 GMER, MS.

GLP-1 medications, such as Wegovy and Zepbound, have experienced blockbuster success since their entry into the market over the past four years, changing the lives of thousands of people living with obesity. What is the science behind GLP-1, and what are the challenges they present? This presentation will review the hype behind this transformative drug, from discovery to its current and future applications.

About Robert F. Kushner, MD, ’82 GMER, MS
A leading scientist who co-authored the pivotal New England Journal of Medicine study that helped spark global interest in GLP-1 medications, Dr. Kushner is professor emeritus of Medicine in the Division of Endocrinology, Metabolism, and Molecular Medicine and of Medical Education at Feinberg.

Arthrex, Inc. Corporate Headquarters
1 Arthrex Way | Naples, Florida 34108

Note: If 1 Arthrex Way doesn’t appear in your navigation app, try using the older map address of 1250 Creekside Parkway | Naples, FL 34108

Advance event registration is required.